In the Original Investigation titled “Efficacy of Losartan in Hospitalized Patients With COVID-19–Induced Lung Injury: A Randomized Clinical Trial,”1 published March 16, 2022, Nastasia James was missing from the list of Angiotensin Receptor Blocker Based Lung Protective Strategies for Inpatients With COVID-19 (ALPS-IP) Investigators. This article has been corrected.1
Error in Nonauthor Collaborators. JAMA Netw Open. 2022;5(5):e2215958. doi:10.1001/jamanetworkopen.2022.15958
Customize your JAMA Network experience by selecting one or more topics from the list below.